初級預防中的心血管風險評估(當代心髒病學)第 1 版。 2022年版
Cardiovascular Risk Assessment in Primary Prevention by Michael D. Shapiro (Editor)
- 發布者 : 人類; 第一版。 1年版(2022年27月2022日)
- 語言 : English
- 格式:原版 pdf/列印副本
- ISBN-10 : 3030988236
- ISBN-13 : 978-3030988234
原價為:166.47 歐元。€13.02目前價格為:13.02 歐元。
This book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. It provides an overview of current evidence regarding approaches to risk assessment, traditional and emerging risk factors, and atherosclerosis imaging for refinement of risk estimation. The volume seeks to provide an essential resource for professionals in the field to assess their patients for risk of cardiovascular disease.
The book is divided into five sections, starting off with an overview of current best practices to risk assessment in primary prevention around the world. The second section discusses traditional risk factors, such as hypercholesterolemia, hypertension, diabetes, smoking, and obesity. The third section reviews the newly introduced concept of ‘Risk Enhancers’. The fourth section offers insight on novel risk factors, with in-depth discussion regarding lipoprotein(a), high-sensitivity CRP, apolipoprotein B, social determinants of health, stress and cardiovascular disease. and polygenic risk scores. The final section covers the use of non-invasive atherosclerosis imaging (computed tomography and ultrasound-based techniques) as a tool to refine risk estimates. Throughout the book, readers will find multiple tables, figures, and illustrations that complement the text.
Up-to-date, evidence-based, and clinically oriented, Cardiovascular Risk Assessment in Primary Prevention is a must-have resource for physicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention.
編輯評論
從封底
This book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. It provides an overview of current evidence regarding approaches to risk assessment, traditional and emerging risk factors, and atherosclerosis imaging for refinement of risk estimation. The volume seeks to provide an essential resource for professionals in the field to assess their patients for risk of cardiovascular disease. The book is divided into five sections, starting off with an overview of current best practices to risk assessment in primary prevention around the world. The second section discusses traditional risk factors, such as hypercholesterolemia, hypertension, diabetes, smoking, and obesity. The third section reviews the newly introduced concept of ‘Risk Enhancers’. The fourth section offers insight on novel risk factors, with in-depth discussion regarding lipoprotein(a), high-sensitivity CRP, apolipoprotein B, social determinants of health, stress and cardiovascular disease. and polygenic risk scores. The final section covers the use of non-invasive atherosclerosis imaging (computed tomography and ultrasound-based techniques) as a tool to refine risk estimates. Throughout the book, readers will find multiple tables, figures, and illustrations that complement the text.
Up-to-date, evidence-based, and clinically oriented, Cardiovascular Risk Assessment in Primary Prevention is a must-have resource for physicians, residents, fellows, and medical students in cardiology, endocrinology, primary care, and health promotion and disease prevention.
關於作者
麥可夏皮羅 is the inaugural Fred M. Parrish Professor of Cardiology and Molecular Medicine at Wake Forest University where he is on faculty in the Section of Cardiovascular Medicine. After completing a cardiology fellowship, Michael spent two additional years in a clinical and research fellowship focused on advanced cardiovascular imaging at Massachusetts General Hospital/Harvard Medical School. After training, he was on faculty in the Knight Cardiovascular Institute at Oregon Health & Science University. He served as Director of Atherosclerosis Imaging and Associate Director of the Center for Preventive Cardiology. In 2019, he transitioned to Wake Forest University where he serves as the Director of the Center for Prevention of Cardiovascular Disease and the Co-Director of the NIH T32 Cardiovascular Disease Epidemiology and Prevention Research Fellowship Program.
Michael’s clinical interests revolve around genetic and acquired disorders of cholesterol and triglycerides, atherosclerosis imaging, genetic predisposition to early myocardial infarction, and cardiovascular risk assessment. Michael has published extensively in the areas of atherosclerosis imaging, lipid disorders, and preventive cardiology. The scope of his research spans translational science, cardiovascular epidemiology, and clinical trials of novel lipid modulating therapeutics. He also serves as a principal investigator on numerous clinical trials testing novel lipid modulating therapeutics.
關於我們 PDF 格式(一般) 阅读更多
相關產品
1個產品結果 正在查看12 451
-
特價!
初級保健中的高級健康評估和臨床診斷第 6 版
原價為:49.29 歐元。€7.44目前價格為:7.44 歐元。 -
特價!
納達斯《小兒心臟病學》第三版
原價為:120.90 歐元。€15.81目前價格為:15.81 歐元。 -
特價!
伯恩斯兒科初級保健第 8 版
原價為:92.99 歐元。€20.46目前價格為:20.46 歐元。 -
特價!
家庭實踐指南第六版
原價為:65.10 歐元。€13.02目前價格為:13.02 歐元。 -
特價!
實證從業人員應用研究滿足顧客需求第二版
原價為:55.80 歐元。€9.30目前價格為:9.30 歐元。 -
特價!
血管和血管內外科專家外科實踐的伴侶第七版
原價為:55.80 歐元。€9.30目前價格為:9.30 歐元。 -
特價!
臨床倫理學 臨床醫學倫理決策的實用方法,第九版 第 9 版
原價為:130.20 歐元。€16.74目前價格為:16.74 歐元。 -
特價!
2024 年初級保健現行實務指南,第 21 版
原價為:83.70 歐元。€15.81目前價格為:15.81 歐元。 -
心臟麻醉和經食道超音波心動圖(蘭格醫學書)
€9.30 -
特價!
初級保健:跨專業協作實踐第七版
原價為:83.70 歐元。€14.88目前價格為:14.88 歐元。 -
特價!
前列腺動脈栓塞術第 1 版。 2020 年版
原價為:65.10 歐元。€8.37目前價格為:8.37 歐元。 -
特價!
先天性心臟病的麻醉第四版 (EPUB)
原價為:55.80 歐元。€6.51目前價格為:6.51 歐元。